Essential role of protein kinase G and decreased cytoplasmic Ca 2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Zhuang, Daming ^a   Ceacareanu, Alice Corina ^a   Ceacareanu, Bogdan ^a   Hassid, Aviv ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

And threonine; Calcium chelator; Glutamate; Hydrogen peroxide; Insulin; Protein tyrosine phosphatase proline; Serine

Indexed keywords

8 BROMO 3',5' CYCLIC MONOPHOSPHOROTHIOATE; ADENOVIRUS VECTOR; CALCIUM CHELATING AGENT; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE 1ALPHA; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLUTAMIC ACID; HYDROGEN PEROXIDE; INSULIN; NITRIC OXIDE; PROLINE; PROTEIN TYROSINE PHOSPHATASE; SERINE; THREONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; CELL CULTURE; CELL MOTILITY; CONTROLLED STUDY; CYTOPLASM; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; RISK FACTOR; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

ANIMALS; AORTA, THORACIC; CALCIUM; CELL MOVEMENT; CELLS, CULTURED; CHELATING AGENTS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYTOPLASM; EGTAZIC ACID; FEMALE; HYDROGEN PEROXIDE; HYPOGLYCEMIC AGENTS; INSULIN; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 15744364460     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01031.2004     Document Type: Article

References (51)

1. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGE)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
2. Bardell AL and MacLeod KM. Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J Pharmacol Exp Ther 296: 252-259, 2001.
3. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol Cell Physiol 271: C1424-C1437, 1996.
4. Brown MR, Miller FJ Jr, Li WG, Ellingson AN, Mozena JD, Chatterjee P, Engelhardt JF, Zwacka RM, Oberley LW, Fang X, Spector AA, and Weintraub NL. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res 85: 524-533, 1999.
5. Buetow BS, Tappan KA, Crosby JR, Seifert RA, and Bowen-Pope DF. Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury. Am J Pathol 163: 979-984, 2003.
6. Ceacareanu AC, Ceacareanu B, Ray RM, Desai LP, Chapman KE, Waters CM, and Hassid A. Nitric oxide attenuates aortic smooth muscle cell motility via decrease of small GTPase Rac1 activity, role of PTP-PEST and p130cas. Circulation 110, Suppl: 389, 2004.
7. Chang Y, Zhuang D, Zhang C, and Hassid A. Increase of PTP levels in vascular injury and in cultured aortic smooth muscle cells treated with specific growth factors. Am J Physiol Heart Circ Physiol 287: H2201-H2208, 2004.
8. Clancy RM, Leszczynska-Piziak J, and Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH Oxidase. J Clin Invest 90: 1116-1121, 1992.
9. Fujii H, Ichimori K, Hoshiai K, and Nakazawa H. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. J Biol Chem 272: 32773-32778, 1997.
10. 2 generation in rat renal mesangial cells. Am J Physiol Renal Physiol 278: F650-F658, 2000.
11. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
12. Gu M, Lynch J, and Brecher P. Nitric oxide increases p21(Waf1/Cip1) expression by a cGMP-dependent pathway that includes activation of extracellular signal-regulated kinase and p70(S6k). J Biol Chem 275: 11389-11396, 2000.
13. Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm A, and Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 180: 733-738, 1994.
14. Hassid A. Atriopeptin II decreases cytosolic free Ca in cultured vascular smooth muscle cells. Am J Physiol Cell Physiol 251: C681-C686, 1986.
15. Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, Stabile E, Perrino C, Chieffo A, Pardo F, and Chiariello M. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperin-sulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103: 2980-2986, 2001.
16. Jones HP, Ghai G, Petrone WF, and McCord JM. Calmodulin-dependent stimulation of the NADPH oxidase of human neutrophils. Biochim Biophys Acta 714: 152-156, 1982.
17. Keller KB and Lemberg L. Obesity and the metabolic syndrome. Am J Crit Care 12: 167-170, 2003.
18. Kubo T, Saito E, Hanada M, Kambe T, and Hagiwara Y. Evidence that angiotensin II, endothelins and nitric oxide regulate mitogen-activated protein kinase activity in rat aorta. Eur J Pharmacol 347: 337-346, 1998.
19. Lee JS, Adrie C, Jacob HJ, Roberts JD Jr, Zapol WM, and Bloch KD. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res 78: 337-342, 1996.
20. Lin Y, Ceacareanu AC, and Hassid A. Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk. Am J Physiol Heart Circ Physiol 285: H710-H721, 2003.
21. Lincoln TM and Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 1: 328-338, 1993.
22. Liu MW, Roubin GS, and King SB III. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79: 1374-1387, 1989.
23. Marks DS, Vita JA, Folts JD, Keaney JF Jr, Welch GN, and Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 96: 2630-2638, 1995.
24. Marumo T, Schini-Kerth VB, Fisslthaler B, and Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 2361-2367, 1997.
25. Meigs JB. Epidemiology of the insulin resistance syndrome. Curr Diab Rep 3: 73-79, 2003.
26. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv Pharmacol 26: 19-33, 1994.
27. Nakazawa M and Imai S. Rp-8-Br-guanosine-3′,5′-cyclic monophosphorothioate inhibits relaxation elicited by nitroglycerin in rabbit aorta. Eur J Pharmacol 253: 179-181, 1994.
28. Pagano PJ, Ho Y, Tornheim K, Gallop PM, Tauber AI, and Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol Heart Circ Physiol 268: H2274-H2280, 1995.
29. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
30. Rao GN. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene 13: 713-719, 1996.
31. 2+-ATPase by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 84: 5685-5689, 1987.
32. Rodenas J, Mitjavila MT, and Carbonell T. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes. Am J Physiol Cell Physiol 274: C827-C830, 1998.
33. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, and Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731-736, 1998.
34. Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, Lassegue B, and King SB III. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation 88: 628-637, 1993.
35. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
36. Shears LL Jr, Kibbe MR, Murdock AD, Billiar TR, Lizonova A, Kovesdi I, Watkins SC, and Tzeng E. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg 187: 295-306, 1998.
37. Shi M, Yang H, Motley ED, and Guo Z. Overexpression of Cu/Zn-superoxide dismutase and/or catalase in mice inhibits aorta smooth muscle cell proliferation. Am J Hypertens 17: 450-456, 2004.
38. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, and Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 21: 739-745, 2001.
39. Sreejayan N, Lin Y, and Hassid A. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism. Arterioscler Thromb Vasc Biol 22: 1086-1092, 2002.
40. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
41. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD, and Griendling KK. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 22: 21-27, 2002.
42. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, McFadden EP, Lablanche JM, and Bertrand ME. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96: 1454-1460, 1997.
43. Vermeersch P, Nong Z, Stabile E, Varenne O, Gillijns H, Pellens M, Van Pelt N, Hoylaerts M, De Scheerder I, Collen D, and Janssens S. L-Arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism. Arterioscler Thromb Vasc Biol 21: 1604-1609, 2001.
44. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, and Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137-1141, 1995.
45. Waldman SA and Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 12: S115-S118, 1988.
46. Watson KE, Peters Harmel AL, and Maison G. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. J Cardiovasc Pharmacol Ther 8: 253-260, 2003.
47. Wernet W, Flockerzi V, and Hofmann F. The cDNA of the two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett 251: 191-196, 1989.
48. Yan Z and Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 82: 21-29, 1998.
49. Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H, Nakata Y, Kutsumi Y, Ohshima S, Nishiyama S, Seki A, Kato K, Nishimura S, Kanoh T, and Yamaguchi H. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol 30: 855-862, 1997.
50. Yoshida Y, Mitsumata M, Ling G, Jiang J, and Shu Q. Migration of medial smooth muscle cells to the intima after balloon injury. Ann NY Acad Sci 811: 459-470, 1997.
51. 2 levels: essential role of cGMP. Am J Physiol Heart Circ Physiol 286: H2103-H2112, 2004.